Depressive DisordersAnxiety DisordersCreativityAyahuasca

Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution

This longitudinal study (n=57) investigated the effects of ayahuasca and found improved convergent thinking/creativity, decreased ratings of depression and stress up to four weeks later. These changes were significantly correlated with the level of ego dissolution experienced during the acute trip/ceremony.

Authors

  • Jordi Riba
  • Kim Kuypers
  • Johannes Ramaekers

Published

Psychopharmacology
individual Study

Abstract

Rationale

Ayahuasca is a psychotropic plant tea from South America used for religious purposes by indigenous people of the Amazon. Increasing evidence indicates that ayahuasca may have therapeutic potential in the treatment of mental health disorders and can enhance mindfulness-related capacities. Most research so far has focused on acute and sub-acute effects of ayahuasca on mental health-related parameters and less on long-term effects.

Objectives

The present study aimed to assess sub-acute and long-term effects of ayahuasca on well-being and cognitive thinking style. The second objective was to assess whether sub-acute and long-term effects of ayahuasca depend on the degree of ego dissolution that was experienced after consumption of ayahuasca.

Results

Ayahuasca ceremony attendants (N = 57) in the Netherlands and Colombia were assessed before, the day after, and 4 weeks following the ritual. Relative to baseline, ratings of depression and stress significantly decreased after the ayahuasca ceremony and these changes persisted for 4 weeks. Likewise, convergent thinking improved post-ayahuasca ceremony up until the 4 weeks follow-up. Satisfaction with life and several aspects of mindfulness increased the day after the ceremony, but these changes failed to reach significance 4 weeks after. Changes in affect, satisfaction with life, and mindfulness were significantly correlated to the level of ego dissolution experienced during the ayahuasca ceremony and were unrelated to previous experience with ayahuasca.

Conclusion

It is concluded that ayahuasca produces sub-acute and long-term improvements in affect and cognitive thinking style in non-pathological users. These data highlight the therapeutic potential of ayahuasca in the treatment of mental health disorders, such as depression.

Available with Blossom Pro

Research Summary of 'Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution'

Introduction

Ayahuasca is a traditional Amazonian plant brew that combines DMT-containing Psychotria viridis with MAO-inhibiting Banisteriopsis caapi alkaloids, producing prolonged psychedelic effects. Earlier work has reported acute increases in aspects of mindfulness and divergent thinking during the psychedelic state, anecdotal reports of spiritual insight and improved outlook, and preliminary clinical observations of rapid antidepressant effects lasting days to weeks. However, most research has concentrated on acute and sub-acute effects, and there is limited evidence on whether such effects persist over longer intervals or how they relate to aspects of the acute experience such as ego dissolution. Uthaug and colleagues set out to evaluate sub-acute (the day after) and longer-term (4 weeks) changes in affect, mindfulness-related capacities, and cognitive thinking style in naturalistic ceremony attendants. A secondary aim was to test whether these changes were associated with the intensity of ego-dissolution experienced during the ayahuasca ceremony. The researchers hypothesised increases in mindfulness, life satisfaction, and divergent thinking together with reductions in depression, anxiety, and stress, and expected that positive changes would correlate with ego-dissolution ratings and persist at 4 weeks.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (17)

Papers cited by this study that are also in Blossom

Ayahuasca in adolescence: a preliminary psychiatric assessment

da Silveira, D. X., Doering-Silveira, E., Grob, C. S. et al. · Journal of Psychoactive Drugs (2005)

The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization

Frecska, E., Bokor, P., Winkelman, M. J. · Frontiers in Pharmacology (2016)

Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament

Halpern, J. H., Sherwood, A. R., Passie, T. et al. · Medical Science Monitor (2008)

The fibrinolytic system: A new target for treatment of depression with psychedelics

Idell, R. D., Florova, G., Komissarov, A. A. et al. · Medical Hypotheses (2017)

Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking

Kuypers, K. P. C., Riba, &. J., De La Fuente Revenga, &. M. et al. · Psychopharmacology (2016)

Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI)

Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Osório, F. L., Sanches, R. F., Macedo, L. et al. · brazilian Journal of Psychiatry (2015)

420 cited
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network

Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)

Show all 17 references
Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression

Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression a SPECT study

Sanches, R. F., Osório, F. L., Dos Santos, R. G. et al. · Journal of Clinical Psychopharmacology (2016)

380 cited
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities

Soler, J., Elices, M., Franquesa, A. et al. · Psychopharmacology (2015)

Ayahuasca Beyond the Amazon: the Benefits and Risks of a Spreading Tradition

Trichter, S. · Journal of Transpersonal Psychology (2010)

Changes in Spirituality Among Ayahuasca Ceremony Novice Participants

Trichter, S., Klimo, J., Krippner, S. · Journal of Psychoactive Drugs (2009)

75 cited
Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca

Viol, A., Palhano-Fontes, F., Onias, H. et al. · Scientific Reports (2017)

Cited By (66)

Papers in Blossom that reference this study

DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers

Bonomo, Y. A., Norman, A. F., Collins, L. et al. · Frontiers in Psychiatry (2025)

Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT

Reckweg, J. T., Mason, N. L., Theunissen, E. L. et al. · Frontiers in Psychology (2025)

Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis

Caspani, G., Ruffell, S. G. D., Tsang, WF. et al. · Pharmacological Research (2024)

Effects of DMT on mental health outcomes in healthy volunteers

Timmermann, C., Zeifman, R. J., Erritzoe, D. et al. · Scientific Reports (2024)

29 cited
Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study

Mason, N. L., Szabo, A., Kuypers, K. P. C. et al. · Brain Behavior and Immunity - Health (2023)

The ego in psychedelic drug action - ego defenses, ego boundaries, and the therapeutic role of regression

Buchborn, T., Kettner, H., Kartner, L. et al. · Frontiers in Neuroscience (2023)

Cortical structural differences following repeated ayahuasca use hold molecular signatures

Mallaroni, P., Mason, N. L., Kloft, L. et al. · Frontiers in Neuroscience (2023)

6 cited
Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users

Ramaekers, J. G., Mallaroni, P., Kloft, L. et al. · Journal of Cognitive Neuroscience (2023)

13 cited
Show all 66 papers
Meditation Trips: A Thematic Analysis of the Combined Naturalistic Use of Psychedelics With Meditation Practices

Azmoodeh, K., Thomas, E., Kamboj, S. K. · Experimental and Clinical Psychopharmacology (2023)

9 cited
Classic Psychedelic Use and Current Meditation Practice

Simonsson, A., Simonsson, O., Chambers, R. et al. · Mindfulness (2023)

14 cited
Psychedelics and psychological strengths

Brasher, T., Rosen, D., Spinella, M. · International Journal of Wellbeing (2023)

Altered States of Consciousness During Ceremonial San Pedro Use

Bohn, A., Kiggen, M. H. H., Uthaug, M. V. et al. · International Journal for the Psychology of Religion (2022)

Classic psychedelics, health behavior, and physical health

Simonsson, O., Hendricks, P. S., Chambers, R. et al. · Therapeutic Advances in Psychopharmacology (2022)

25 cited
Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey

Bouso, J. C., Andión, O., Sarris, J. et al. · PLOS Global Public Health (2022)

75 cited
Default Mode Network Modulation by Psychedelics: A Systematic Review

Gattuso, J. J., Perkins, D., Ruffell, S. G. D. et al. · International Journal of Neuropsychopharmacology (2022)

Nootropic effects of LSD: Behavioral, molecular and computational evidence

Ornelas, I. M., Cini, F. A., Wießner, I. et al. · Experimental Neurology (2022)

25 cited
Being no one, being One: The role of ego-dissolution and connectedness in the therapeutic effects of psychedelic experience

Kałużna, A., Schlosser, M., Gulliksen Craste, E. et al. · Journal of Psychedelic Studies (2022)

35 cited
Towards an understanding of psychedelic-induced neuroplasticity

Calder, A. E., Hasler, G. · Neuropsychopharmacology (2022)

Psychedelics and mindfulness: A systematic review and meta-analysis

Radakovic, C., Radakovic, R., Peryer, G. et al. · Journal of Psychedelic Studies (2022)

Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees

Kiraga, M. K., Kuypers, K. P. C., Uthaug, M. V. et al. · Frontiers in Psychiatry (2022)

20 cited
LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility

Wießner, I., Olivieri, R., Falchi, M. et al. · European Neuropsychopharmacology (2022)

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)

Reckweg, J., Uthaug, M. V., Szabo, A. et al. · Journal of Neurochemistry (2022)

LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking

Wießner, I., Falchi, M., Maia, L. O. et al. · Journal of Psychopharmacology (2022)

32 cited
Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States

Simonsson, O., Goldberg, S. B. · Journal of Psychoactive Drugs (2022)

21 cited
Sub-acute and long-term effects of ayahuasca on mental health and well-being in healthy ceremony attendants: A replication study

van Oorsouw, K., Uthaug, M. V., Mason, N. L. et al. · Journal of Psychedelic Studies (2021)

17 cited
Persisting effects of ayahuasca on empathy, creative thinking, decentering, personality, and well-being

Kiraga, M. K., Mason, N. L., Uthaug, M. V. et al. · Frontiers in Pharmacology (2021)

56 cited
Prefrontal contributions to the stability and variability of thought and conscious experience

Zamani, A., Carhart-Harris, R. L., Christoff, K. · Neuropsychopharmacology (2021)

Improving cognitive functioning in major depressive disorder with psychedelics: a dimensional approach

Kuiperes, Z., Schreiber, R. · Neurobiology of Learning and Memory (2021)

Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use

Hübner, S., Haijen, E. C. H. M., Kaelen, M. et al. · Journal of Medical Internet Research (2021)

Does psychedelic therapy have a transdiagnostic action and prophylactic potential?

Kočárová, C., Horacek, J., Carhart-Harris, R. L. · Frontiers in Psychiatry (2021)

73 cited
LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model

Wießner, I., Falchi, M., Palhano-Fontes, F. et al. · Psychological Medicine (2021)

Ceremonial Ayahuasca in Amazonian Retreats-Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study

Ruffell, S. G. D., Netzband, N., Tsang, W. et al. · Frontiers in Psychiatry (2021)

56 cited
Psychedelic medicalization, public discourse, and the morality of ego dissolution

Gearin, A. K., Devenot, N. · International Journal of Cultural Studies (2021)

Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives

Cox, D. J., Garcia-Romeu, A., Johnson, M. W. · The American Journal of Drug and Alcohol Abuse (2021)

Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects

Aday, J. S., Davis, A. K., Mitzkovitz, C. M. et al. · ACS Pharmacology and Translational Science (2021)

Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine

O'shaughnessy, D. M., Berlowitz, I., Rodd, R. et al. · Therapeutic Advances in Psychopharmacology (2021)

The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study

Maia, L. O., Daldegan-Bueno, D., Tófoli, L.F. · Journal of Psychoactive Drugs (2020)

21 cited
Psychedelics and virtual reality: parallels and applications

Aday, J. S., Davoli, C. C., Bloesch, E. K. · Therapeutic Advances in Psychopharmacology (2020)

82 cited
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland

Kangaslampi, S., Hausen, A., Rauteenmaa, T. · Journal of Psychoactive Drugs (2020)

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin

Mason, N. L., Kuypers, K. P. C., Reckweg, J. et al. · Neuropsychopharmacology (2020)

Long-term effects of psychedelic drugs: A systematic review

Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)

Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination

Jiménez-Garrido, D. F., Gómez-Sousa, M., Ona, G. et al. · Scientific Reports (2020)

Classic psychedelics as therapeutics for psychiatric disorders

Nichols, C. D., Hendricks, P. S. · Handbook of Behavioral Neuroscience (2020)

Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety

Davis, A. K., Barrett, F. S., Griffiths, R. R. · Journal of Contextual Behavioral Science (2020)

The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.

Araújo, D. B., Zeifman, R. J., Palhano-Fontes, F. et al. · Frontiers in Pharmacology (2019)

96 cited
Cessation and reduction in alcohol consumption and misuse after psychedelic use

Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)

211 cited
Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being

Mason, N. L., Mischler, E., Uthaug, M. V. et al. · Journal of Psychoactive Drugs (2019)

136 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Sub-acute and long-term effects of ayahuasca on... — Research Summary & Context | Blossom